Morristown, NJ, United States of America

Meghan E Casey

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 47(Granted Patents)


Location History:

  • Morristown, NJ (US) (2022)
  • Ringwood, NJ (US) (2021 - 2024)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Meghan E. Casey

Introduction

Meghan E. Casey is a prominent inventor based in Morristown, NJ, known for her contributions to biochemistry and cell culture technologies. With a total of 13 patents to her name, she has significantly influenced the field of protein production and therapeutic development.

Latest Patents

Meghan's most recent innovations include two noteworthy patents. The first is related to "Taurine supplemented cell culture medium and methods of use," which describes an enhanced eukaryotic cell culture medium that can be utilized for producing proteins of interest. This innovation allows for the addition of taurine to serum-free or chemically-defined media to boost protein production. Furthermore, it includes methods for recombinantly expressing high levels of protein using these specialized media compositions.

Her second latest patent is titled "Anti-VEGF protein compositions and methods for producing the same." This disclosure highlights compositions that comprise anti-VEGF proteins, along with methods for their production, which have significant implications in medical therapies targeting angiogenesis.

Career Highlights

Throughout her career, Meghan has made an impact while working at notable biotechnology companies, including Regeneron Pharmaceuticals, Inc. There, she honed her expertise in developing advanced protein production methodologies that have contributed to the company's research and therapeutic offerings.

Collaborations

Meghan has collaborated with esteemed professionals in her field, including coworkers Amy S. Johnson and Shawn M. Lawrence. These partnerships have enabled her to blend innovative ideas and drive forward the research initiatives within her teams.

Conclusion

Meghan E. Casey's work exemplifies the intersection of innovation and practicality in biotechnology. Her patents not only illustrate her inventiveness but also reflect her commitment to enhancing biopharmaceutical production capabilities. As she continues her journey, her contributions remain influential in shaping the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…